Log In
Print
BCIQ
Print
Print this Print this
 

WT1 DNA vaccine

  Manage Alerts
Collapse Summary General Information
Company Inovio Pharmaceuticals Inc.
DescriptionLeukemia DNA vaccine targeting Wilms' tumor gene 1
Molecular Target Wilms tumor 1 (WT1)
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: DNA vaccine
Latest Stage of DevelopmentPhase II
Standard IndicationLeukemia
Indication DetailsTreat chronic myelogenous leukemia (CML) and acute myelogenous leukemia (AML)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today